See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot4,012▼ 0.30%WTI103.44▲ 3.99%
← BICO page
XStocksXray
Market X-Ray report · 23 October 2026

BICO Group AB (BICO)

Stockholm Exchange · Sweden · prices in SEK · close of 23 Oct 2026

Key indicators

Last closeSEK 24.05
52-week range12.94 – 25.42
Return, 1 month / 3 months+6.9% / +80.8%
Return, 1 year / 3 years+5.6% / −11.1%
TrendUptrend
RSI (14)62
Volatility (1 year)53.1%
Worst drawdown (1 year)-45.6%
Average daily value traded6.38M SEK
Dividend yield–

Market X-Ray price-based

73/ 100 · High confidence · ahead of 83% of stocks on this exchange
Trend94
Momentum81
Stability (higher is calmer)45
Liquidity75
Income–

Five-year price chart navy: price · brown: 200-day average

-15.811192533885222021-102023-012024-042025-072026-10

About the company

BICO Group is a Swedish life-science company that builds instruments and systems for biological research and production. Its products include bioprinters, laboratory automation equipment, dispensers and cell-handling tools used by researchers in pharmaceutical companies, academic laboratories and diagnostics developers. The company is based in Gothenburg, Sweden, and supplies customers around the world through its own brands and sales channels.

The shares are listed on the Stockholm Exchange in Sweden under the code BICO, and the price on this page is in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

BICO Group AB (BICO) trades on the Stockholm Exchange in Sweden. It last closed at SEK 24.05 on 23 October 2026.

Its price-based Market X-Ray is 73 out of 100 (a strong price profile), ranking 154 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 5.6% and over the last three months it rose 80.8%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
BICO Group AB (BICO)

The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange

Lens and metricValueScoreReading
Trend94 · StrongTrading above its long-term averages and near its highs.
Above 200-day average31.0%
From 52-week high-3.4%
Momentum81 · StrongRising faster than most stocks on this exchange.
3-month return80.8%
6-month return19.7%
12-month return, skipping the last month-1.2%
Stability (higher is calmer)45 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)53.1%
Worst drawdown, 1 year (smaller is calmer)-45.6%
Liquidity75 · StrongTrades actively.
Average daily value traded6.38M SEK
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.
  • Liquidity: Trades actively.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−0.8%
1 month+6.9%
3 months+80.8%
6 months+19.7%
1 year+5.6%
3 years−11.1%
5 years−95.1%

Signals

50-day / 200-day average21.79 / 18.36
Golden / death cross (60 days)Golden, 23 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.98

Technical summary

DailyStrongly bullish11 bullish · 4 neutral · 1 bearish
WeeklyBullish8 bullish · 1 neutral · 3 bearish
MonthlyNeutral4 bullish · 1 neutral · 3 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 23 Oct 2026